Paul Mesko
About Paul Mesko
Paul Mesko is a Research Associate 2 at Bristol-Myers Squibb in New Jersey, specializing in hybridoma development and antibody generation.
Current Position at Bristol-Myers Squibb
Paul Mesko currently holds the position of Research Associate 2 at Bristol-Myers Squibb in New Jersey, United States. Since joining the company in September 2014, he has been actively involved in antibody generation and hybridoma development for both therapeutic and reagent projects. His role includes supporting B cell studies using multicolor flow cytometry techniques, reflecting his specialized expertise in the field.
Previous Experience at Santa Cruz Biotechnology
Paul Mesko previously worked at Santa Cruz Biotechnology in Dallas, Texas, United States. From 2008 to 2014, he served as a Research Associate and then advanced to Research Associate 2. During his six-year tenure, he focused on similar areas of expertise, including hybridoma development and antibody generation. His responsibilities also involved optimizing laboratory protocols to improve efficiency and developing strong troubleshooting skills in proteomics-related laboratory techniques.
Education and Biochemistry Background
Paul Mesko earned his Bachelor of Science degree in Biochemistry from California Polytechnic State University - San Luis Obispo. His educational background provided a solid foundation in biochemical principles, which he has applied throughout his career in both research and applied laboratory settings. The knowledge and skills acquired during his studies have been crucial to his success in antibody generation and hybridoma development.
Specialization in Antibody Generation and Hybridoma Development
Paul Mesko specializes in hybridoma development and antibody generation for both therapeutic and reagent projects. His expertise extends to supporting B cell studies using multicolor flow cytometry techniques. Known for his ability to optimize laboratory protocols, Paul brings a level of efficiency and innovation to his work that enhances research outcomes. He also possesses strong troubleshooting skills in proteomics-related laboratory techniques, making him a valuable asset in the research environment.